Prevention of mother-to-child transmission of infections during pregnancy: implementation of recommended interventions, United States, 2003-2004.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 22030318.
- Also identified by DOI 10.1016/j.ajog.2011.08.027 and PMC identifier 4707941.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The objective of the study was to describe prenatal screening, positive test rates, and the administration of indicated interventions for hepatitis B, rubella, syphilis, group B streptococcus (GBS), chlamydia, and gonorrhea in the United States using 2 population-based surveys. Both surveys abstracted demographic, prenatal, and delivery data from a representative sample of delivering women in 10 states. Analyses accounted for the complex sampling design. Among the 7691 and 19,791 women in the 2 studies, screened proportions before delivery were more than 90% for hepatitis B and rubella, 80% for syphilis, 72-85% for GBS, and less than 80% for chlamydia and gonorrhea. Inadequate prenatal care was the strongest factor associated with no screening. Administration of interventions indicated by positive test results was variable but generally low. Improved prenatal screening and administration of indicated treatments or interventions, particularly for syphilis, GBS, chlamydia, and gonorrhea, will further protect newborns from infection.
Medical subject headings
- Chlamydia Infections
- Gonorrhea
- Hepatitis B
- Infectious Disease Transmission, Vertical
- Pregnancy Complications, Infectious
- Rubella
- Streptococcal Infections
- Syphilis